Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083

Autor: Mitchell, Kate M., Boily, Marie-Claude, Hanscom, Brett, Moore, Mia, Todd, Jeffery, Paz-Bailey, Gabriela, Wejnert, Cyprian, Liu, Albert, Donnell, Deborah J., Grinsztejn, Beatriz, Landovitz, Raphael J., Dimitrov, Dobromir T.
Zdroj: In The Lancet Regional Health - Americas February 2023 18
Databáze: ScienceDirect